Aaron Pearson
Vice President of Public Relations
June 10, 2020
While the COVID-19 pandemic has begun to ease in the United States and governments similarly move from stay-at-home orders to an easing of restrictions, testing remains key to limiting the spread of the virus, and Stratasys is working hard to help testing centres gain access to the nasopharyngeal (NP) swabs they need.
According to the COVID Tracking Project, new tests across the country have been above 300,000 nearly every day since mid-May, with a new high of 545,690 tests reported on Friday, June 5. This is more than twice the rate of testing reported in mid-April. The demand continues to grow.
Since early May, Stratasys has been marketing and promoting Origin 3D-printed nasal swabs to healthcare providers and other testing centres in the U.S. And now, all these NP swabs (NP-01-S) are sterile, individually packaged, and ready to use out of the box.
The Origin 3D-printed NP swab (NP-01-S) has been tested in a clinical trial and is considered an FDA Class I Exempt Device. The trial was conducted by Beth Israel Deaconess Medical Centre, an academic medical centre affiliated with Harvard Medical School.
Learn how ECCO adopted the direct injection process to improve footwear manufacturing and selected the Origin One 3D printer. Origin One’s surface quality, print speed, accuracy, and ability to print large cross-sections stood out from the alternative solutions which ECCO tested. In addition, Origin works with leading resin partners to develop next-generation materials, which were also critical to ECCO’s needs. ECCO started working with the Origin team in late 2018.
View moreStratasys Origin One flexible production capability produces end-use parts for Nissan’s Super GT racing team
View moreA lesser-known challenge for many if not all 3D printing technologies is the ability to print large bulky parts without sacrificing part quality. Whether it be thermal gradients, internal stresses, or throughput hurdles; most 3D printing technologies must overcome at least one of these factors. In the case of DLP printing it’s all the above. In this presentation from Marshall Ling, Origin Senior Research Engineer at Stratasys, discover how a programmable print process approach is used to enable new applications in a previously inaccessible space. Learn from real-world examples that demonstrate how the Origin One produces advanced geometries, like large solid moulds or smaller densely nested parts
View moreLearn how ECCO adopted the direct injection process to improve footwear manufacturing and selected the Origin One 3D printer. Origin One’s surface quality, print speed, accuracy, and ability to print large cross-sections stood out from the alternative solutions which ECCO tested. In addition, Origin works with leading resin partners to develop next-generation materials, which were also critical to ECCO’s needs. ECCO started working with the Origin team in late 2018.
Stratasys Origin One flexible production capability produces end-use parts for Nissan’s Super GT racing team
A lesser-known challenge for many if not all 3D printing technologies is the ability to print large bulky parts without sacrificing part quality. Whether it be thermal gradients, internal stresses, or throughput hurdles; most 3D printing technologies must overcome at least one of these factors. In the case of DLP printing it’s all the above. In this presentation from Marshall Ling, Origin Senior Research Engineer at Stratasys, discover how a programmable print process approach is used to enable new applications in a previously inaccessible space. Learn from real-world examples that demonstrate how the Origin One produces advanced geometries, like large solid moulds or smaller densely nested parts